Praxis

Posted on by

For my ecofeminist activist action I decided to focus on the issue of environmental gentrification, particularly in the state of Massachusetts. Currently Los Angeles, Washington, D.C., Philadelphia, Baltimore, San Diego, New York, and Chicago account for nearly half of the gentrification within the United States. Gentrification refers to “what happens when lower-income neighborhoods receive massive levels of new investment, adding amenities, raising home values and bringing in new upper-income residents” (Wiltse-Ahmad). While some my view gentrification as a positive as we’ve learned within our previous blog post it often leads to negative impacts like forced displacement and a discriminatory behaviors by people in power towards low-income individuals and people of color. As a result, plenty of individuals end up homeless or living in communities which have more environmental burdens than benefits. Sadly, Boston landed the 20th slot in the cities listed by the intensity of gentrification between the years 2000-2013. While in comparison to the top seven cities Boston is quite low it is still contributing to the problem nationwide.

Thus, I plan to start a tweeter page to share awareness within our state. I would like to educate those on the realties of gentrification and how naturally it can occur. For example, within New Bedford (where I grew up) there have been some major improvements towards the downtown area made to promote tourism. And while the number of homeless individuals have grown within the city all the local news reports many focus on is the benefits associated with the “beatification”. I would like to post pictures of local areas such as Boston, Cambridge, and Lowell communities which have been gentrified. I would also focus on highlight the number of power plants and waste facilities within the cities and towns, as well as poor health outcomes. After highlighting the negative effects associated with gentrification I plan on introducing positive movements in which these communities can learn from. Movements such as Majora Carter’s “Greening the Ghetto,” which brings in sustainable initiatives to improve the lives of those living in communities subject to environmental racism.

By making this tweeter campaign I hope to further educate those of whom don’t fully understand gentrification and how quickly it can take over communities. I would also like to relay the information on how as a community members can empower one another to work together in order to stand against tactics of gentrification. I believe my plan will be successful, because not only individuals be able to learn what gentrification truly is. The hope is they will continue to spread the word and teacher older family members who may feel powerless when faced with the threat of displacement. Ultimately, spreading awareness will make someone feel less hopeless.

 

Sources:

https://ncrc.org/study-gentrification-and-cultural-displacement-most-intense-in-americas-largest-cities-and-absent-from-many-others/

https://www.wgbh.org/news/local-news/2019/07/11/in-massachusetts-an-uneven-impact-from-rising-rents

Examining the Negative Impacts of Gentrification

 

15 thoughts on “Praxis”

  1. Hello,
    I think it is a great idea to spread awareness of gentrification. I like how you not only planned on stating the issues, but stating possible solutions. I hope in doing this, you not only show them the facts, but perhaps can obtain statements from both sides of people affected by and affecting gentrification. It would be cool to see the twitter page become essentially a resource that has not only reputable sources of facts and arguments, but primary sources taken from the people experiencing its affects as well. Perhaps you could even start a movement that encourages people to take care of each other and become less dependant on the central power and more reliant on themselves and neighbors.

    Reply ↓

  12. Ipamorelin and Sermorelin are two of the most frequently discussed peptides in the realm of anti-aging therapy and performance
    enhancement. Though both belong to the class of
    growth hormone secretagogues, their pharmacological profiles,
    clinical uses, administration protocols, and side-effect spectrums differ
    markedly. Below is an exhaustive comparison that covers mechanism of action, dosing nuances, therapeutic benefits, safety considerations,
    and practical tips for individuals looking to combine these agents or consider them separately.

    Ipamorelin vs Sermorelin: Comprehensive Comparison and Guide

    Feature Ipamorelin Sermorelin

    Molecular Class Peptide growth hormone secretagogue
    (PHS) – ghrelin receptor agonist Growth hormone releasing hormone analogue (GHRH
    analog)

    Sequence & Size 5-mer peptide: Trp-Glu-Ala-Leu-Lys-NH2 23-aa GHRH
    analog (modified to resist enzymatic degradation)

    Primary Receptor Target Ghrelin receptor (GHS-R1a) on pituitary
    somatotrophs GHRH receptor (GHRH-R) on pituitary somatotrophs

    Mechanism of Action Mimics endogenous ghrelin;
    stimulates GH release via GHS-R1a activation, leading to downstream increases in IGF-1 and prolactin Binds to GHRH
    receptors; promotes natural GH secretion pattern with pulsatile peaks similar to physiological rhythm

    Onset & Duration of Action Rapid onset (~10–15 min post-subcutaneous injection); peak at 30–45 min, effect lasts ~2–3 h Onset slightly slower (20–30 min);
    GH pulse peaks at ~60–90 min, duration ~4–6 h

    Dosing Frequency Typically 1–3 times daily;
    common regimens: 100–200 µg before bed and/or pre-workout.
    Usually 2–3 times daily; typical doses 300–600 µg per injection.

    Administration Route Subcutaneous (SC) or intranasal
    (IN) SC only; IN not effective due to peptide size

    Half-Life ~30 min in plasma, but sustained effect due
    to receptor binding ~2–4 h with modified stability

    Side-Effect Profile Mild edema at injection site, transient flushing, increased appetite.

    Rare cases of hyperglycemia or water retention. Similar mild side effects; some
    patients experience nausea or headaches.

    Hormonal Specificity Highly selective for GH and prolactin release; minimal stimulation of
    cortisol or ACTH Also stimulates IGF-1 production but less prolactin activity

    Clinical Indications Short-term use for muscle wasting, cachexia, or as
    a research tool. Not FDA approved for any indication in the US.
    Investigational therapy for growth hormone deficiency; often used off-label for anti-aging.

    Cost & Availability Generally cheaper per dose due to shorter peptide
    chain and simpler synthesis. Slightly higher cost because
    of longer sequence and more complex manufacturing.

    Legal Status Classified as a research chemical in many jurisdictions; not approved for human use by regulatory agencies.
    Also a research compound; some countries allow therapeutic use under special permits.

    Practical Usage Scenarios

    Anti-Aging Protocols – Individuals seeking
    to boost IGF-1 and GH levels may prefer Sermorelin because it mimics
    the natural circadian rhythm of hormone release, potentially leading to more physiologic outcomes
    such as improved sleep architecture and metabolic health.

    Muscle Mass & Recovery – Ipamorelin’s rapid onset makes it popular among athletes who want a quick
    surge in GH before training or post-exercise for muscle repair.
    The modest prolactin rise may also support anabolic
    processes.

    Combination Therapy – Some practitioners recommend alternating between the two peptides on different days to leverage both
    mechanisms: use Sermorelin in the morning and Ipamorelin at night.

    This strategy can provide a broader GH pulse coverage without excessive dosing.

    Safety Monitoring – Regular bloodwork (IGF-1, fasting glucose, lipid profile) is essential
    for both agents, especially when used chronically or in higher doses.
    Keep injection sites rotated to avoid lipodystrophy.

    Book a Call

    If you are considering incorporating either Ipamorelin or Sermorelin into your health regimen and would like
    personalized guidance, it’s advisable to schedule a professional consultation. A qualified endocrinologist
    or peptide specialist can evaluate your hormone baseline, medical history, and
    specific goals before recommending a tailored dosing
    protocol. Many clinics offer virtual appointments that allow you to discuss the nuances of each peptide, potential interactions with other supplements,
    and monitoring plans.

    When booking a call:

    Prepare: Bring recent lab results (IGF-1, GH, cortisol, glucose).

    Clarify Goals: Whether you aim for anti-aging benefits, athletic performance,
    or muscle recovery.

    Discuss Risks: Understand potential side effects, contraindications, and legal status
    in your region.

    Most reputable practitioners will provide a written treatment plan and
    supply verified peptide products from GMP-certified manufacturers.
    Ensure that any purchase is compliant with local regulations to
    avoid counterfeit or contaminated substances.

    Ipamorelin Mechanism

    Ipamorelin exerts its effect by acting as an agonist at the growth hormone secretagogue receptor 1a (GHS-R1a).
    The peptide binds to this receptor located
    on somatotroph cells in the anterior pituitary. Upon binding,
    intracellular signaling cascades involving phospholipase C
    and protein kinase pathways are activated, leading to calcium influx and
    subsequent exocytosis of stored growth hormone.

    Key aspects of Ipamorelin’s mechanism include:

    Receptor Specificity – Unlike other secretagogues
    such as GHRP-6 or hexarelin, Ipamorelin has a high affinity for the ghrelin receptor while
    sparing the prolactin-stimulating pathways to a greater extent.
    This results in a more favorable side-effect profile.

    Feedback Regulation – The peptide’s action does not directly inhibit the hypothalamic release of
    growth hormone-inhibiting hormone (somatostatin).
    Instead, it stimulates GH secretion in a pulsatile manner that mimics physiological patterns, thereby reducing the risk
    of desensitization.

    IGF-1 Induction – The released GH travels to the liver and peripheral tissues, where it induces production of insulin-like growth factor
    1 (IGF-1). IGF-1 mediates many anabolic effects such as protein synthesis,
    muscle hypertrophy, and bone density improvement.

    Metabolic Effects – By increasing GH and IGF-1 levels, Ipamorelin can enhance lipolysis,
    reduce visceral fat, and improve insulin sensitivity over time.
    These metabolic benefits are often sought in anti-aging protocols.

    Safety Modulators – Because the peptide is short (only five amino acids) and lacks a large hydrophobic tail, it has lower propensity to bind non-target proteins.
    This reduces off-target activity and keeps the side-effect spectrum mild compared with longer secretagogues.

    In summary, Ipamorelin’s mechanism is tightly
    focused on stimulating growth hormone release through ghrelin receptor activation while maintaining a low side-effect burden. When used in conjunction with Sermorelin or as part of an individualized protocol, it
    can provide a versatile tool for both therapeutic and
    performance-enhancing objectives.

    Reply ↓

Leave a Reply to gitea.vidoks.fr Cancel reply

Your email address will not be published. Required fields are marked *